Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03798197Phase 1Completed
Phase 1, randomised, open-label trial of estetrol in menopause (2 arms), sponsored by Donesta Bioscience B.V. Primary endpoints: Maximum concentration of Estetrol in plasma, Area under the curve from time zero to the last determinable concentration and 1 more. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03798197.